News from June 2024

June 27, 2024

Alzheimer’s vision study improved with home tests

Research looking at the link between Alzheimer’s disease and eye problems is based on ongoing ACT study started in 1994.

Categories: Science Updates, News

June 20, 2024

Alzheimer’s drug donanemab backed by FDA advisory panel

"Donanemab's compelling clinical trial outcome not only confirms that this treatment strategy is effective in treating Alzheimer's disease, but also provides clinicians additional opportunities to tailor the amyloid monoclonal antibody to the individual patient," said MBWC Clinical Trials Director, Michael Rosenbloom, MD

Categories: Science Updates, New FDA Drug Approvals, News

June 07, 2024